Insider Transactions in Q3 2022 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,052
-9.99%
|
$152,416
$8.54 P/Share
|
|
Sep 21
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+16.43%
|
-
|
|
Jul 18
2022
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-13.67%
|
$26,274
$6.7 P/Share
|
|
Jul 18
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
11,111
+25.75%
|
$0
$0.45 P/Share
|